Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease (original) (raw)

\u3csup\u3e1\u3c/sup\u3eH-MRS Metabolites in Adults with Down Syndrome: Effects of Dementia

Gregory Jicha

2016

View PDFchevron_right

1H-MRS metabolites in adults with Down syndrome: Effects of dementia

Gregory Jicha

NeuroImage: Clinical, 2016

View PDFchevron_right

Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome

Yannick Vermeiren

Journal of Alzheimer's disease : JAD, 2015

View PDFchevron_right

The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy

Akihiko Shiino

Journal of Cerebral Blood Flow & Metabolism, 2012

View PDFchevron_right

Regional Gray and White Matter Metabolite Differences in Subjects With AD, With Subcortical Ischemic Vascular Dementia, and Elderly Controls With 1H Magnetic Resonance Spectroscopic Imaging

George Fein

Archives of Neurology, 1996

View PDFchevron_right

The heritability of brain metabolites on proton magnetic resonance spectroscopy in older individuals

Perminder Sachdev

NeuroImage, 2012

View PDFchevron_right

Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome

Bradley Christian

Journal of Alzheimer's disease : JAD, 2018

View PDFchevron_right

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia

Melina Uncapher

Neurology, 2003

View PDFchevron_right

Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome

Elizabeth Head

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012

View PDFchevron_right

Down syndrome, increased risk of dementia and lipid disturbances

Maciej Jankowski

Journal of mother and child, 2021

View PDFchevron_right

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains

jorge bahena

2021

View PDFchevron_right

The “develOpment of metabolic and functional markers of Dementia IN Older people” (ODINO) Study: Rationale, Design and Methods

Jacopo Gervasoni

Journal of Personalized Medicine, 2020

View PDFchevron_right

Metabolic signatures of human Alzheimer’s disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue

Stewart Graham

Metabolomics, 2013

View PDFchevron_right

Exploring Changes in Primary Metabolites in Alzheimer ’ s Disease using Targeted LC-MS / MS MSACL 2016 EU

Nicola Gray

2016

View PDFchevron_right

Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults

Hamid R Sohrabi

Journal of Neurochemistry, 2020

View PDFchevron_right

Age-Related Changes in Plasma Dehydroepiandrosterone Levels in Adults with Down’s Syndrome and the Risk of Dementia

Joe Herbert

Journal of Neuroendocrinology, 2011

View PDFchevron_right

Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis

Jingyun Yang

Neurobiology of Aging, 2019

View PDFchevron_right

Hippocampal Volumes, Proton Magnetic Resonance Spectroscopy Metabolites, and Cerebrovascular Disease in Mild Cognitive Impairment Subtypes

Maria Shiung

Archives of Neurology, 2008

View PDFchevron_right

Magnetic Resonance Spectroscopy in Alzheimer’s Disease: Systematic Review and Meta-Analysis

Wen-Ying Wang

Journal of Alzheimer's Disease, 2015

View PDFchevron_right

Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis

Frederick Schmitt

Frontiers in aging neuroscience, 2018

View PDFchevron_right

Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging

Frank Ezekiel, Brian Soher

Alzheimer Disease & Associated Disorders, 2006

View PDFchevron_right

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study

Shona Pedersen

Metabolomics, 2024

View PDFchevron_right

Recent advances in the application of metabolomics to Alzheimer's Disease

Eugenia Trushina

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013

View PDFchevron_right

Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: A 1H-MRS study

Yves De Deene

European Journal of Radiology, 2012

View PDFchevron_right

A Longitudinal Study of Dementia of Alzheimer Type in Down's Syndrome

Arne Brun

Dementia and Geriatric Cognitive Disorders, 1991

View PDFchevron_right

Discrepancy between Alzheimer-Type Neuropathology and Dementia in Persons with Down's Syndrome

Ausma Rabe

Annals of The New York Academy of Sciences, 1986

View PDFchevron_right

Plasma metabolome and cognitive skills in Down syndrome

Chiara Locatelli

Scientific Reports

View PDFchevron_right